Star Combo Pharma Stock Price To Earnings To Growth
| S66 Stock | 0.14 0.00 0.00% |
Star Combo Pharma fundamentals help investors to digest information that contributes to Star Combo's financial success or failures. It also enables traders to predict the movement of Star Stock. The fundamental analysis module provides a way to measure Star Combo's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Star Combo stock.
Star | Price To Earnings To Growth |
Star Combo Pharma Company Price To Earnings To Growth Analysis
Star Combo's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Star Combo Pharma has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Personal Care Products sector and 100.0% lower than that of the Consumer Staples industry. The price to earnings to growth for all Australia stocks is 100.0% higher than that of the company.
Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Star Fundamentals
| Return On Equity | 0.0224 | ||||
| Return On Asset | 0.0136 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 16.26 M | ||||
| Shares Outstanding | 135.08 M | ||||
| Shares Owned By Insiders | 93.57 % | ||||
| Price To Book | 0.59 X | ||||
| Price To Sales | 0.75 X | ||||
| Revenue | 26.02 M | ||||
| Gross Profit | 5.71 M | ||||
| EBITDA | 2.79 M | ||||
| Net Income | 747.33 K | ||||
| Cash And Equivalents | 6.5 M | ||||
| Total Debt | 4.03 M | ||||
| Book Value Per Share | 0.25 X | ||||
| Cash Flow From Operations | (316.45 K) | ||||
| Earnings Per Share | 0.01 X | ||||
| Beta | 0.45 | ||||
| Market Capitalization | 19.59 M | ||||
| Total Asset | 42.82 M | ||||
| Retained Earnings | (10.08 M) | ||||
| Working Capital | 13.77 M | ||||
| Annual Yield | 0.03 % | ||||
| Net Asset | 42.82 M | ||||
| Last Dividend Paid | 0.004 |
About Star Combo Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Star Combo Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Star Combo using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Star Combo Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Star Stock Analysis
When running Star Combo's price analysis, check to measure Star Combo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Star Combo is operating at the current time. Most of Star Combo's value examination focuses on studying past and present price action to predict the probability of Star Combo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Star Combo's price. Additionally, you may evaluate how the addition of Star Combo to your portfolios can decrease your overall portfolio volatility.